






Xinjing Tang et al. 
Caged circular siRNAs for photomodulation of gene 






This is an Accepted Manuscript, which has been through the  
Royal Society of Chemistry peer review process and has been 
accepted for publication.
Accepted Manuscripts are published online shortly after acceptance, 
before technical editing, formatting and proof reading. Using this free 
service, authors can make their results available to the community, in 
citable form, before we publish the edited article. We will replace this 
Accepted Manuscript with the edited and formatted Advance Article as 
soon as it is available.
You can find more information about Accepted Manuscripts in the 
Information for Authors.
Please note that technical editing may introduce minor changes to the 
text and/or graphics, which may alter content. The journal’s standard 
Terms & Conditions and the Ethical guidelines still apply. In no event 
shall the Royal Society of Chemistry be held responsible for any errors 
or omissions in this Accepted Manuscript or any consequences arising 




This article can be cited before page numbers have been issued, to do this please use:  J. Groen, A.
Palanca, A. Aires, J. Conesa, D. Maestro, S. Rehbein, M. Harkiolaki, A. V. Villar, A. L. Cortajarena and E.
Pereiro, Chem. Sci., 2021, DOI: 10.1039/D1SC04183E.
ARTICLE
Please do not adjust margins
Please do not adjust margins
Received 00th January 20xx,
Accepted 00th January 20xx
DOI: 10.1039/x0xx00000x
Correlative 3D cryo X-ray imaging reveals 
intracellular location and effect of designed 
antifibrotic protein-nanomaterial hybrids 
J. Groena, A. Palancab, c, A. Aires d, J.J. Conesa a, e, D. Maestrob, S. Rehbeinf, M. Harkiolakig, A. Villarb, 
h, A.L. Cortajarenad, i*, E. Pereiroa*
Revealing the intracellular location of novel therapeutic agents is paramount for the understanding of their effect at the cell 
ultrastructure level. Here, we apply a novel correlative cryo 3D imaging approach to determine the intracellular fate of a 
designed protein-nanomaterial hybrid with antifibrotic properties that shows great promise in mitigating myocardial 
fibrosis. Cryo 3D structured illumination microscopy (cryo-3D-SIM) pinpoints the location and cryo soft X-ray tomography 
(cryo-SXT) reveals the ultrastructural environment and subcellular localization of this nanomaterial with spatial correlation 
accuracy down to 70 nm in whole cells. This novel high resolution 3D cryo correlative approach unambiguously locates the 
nanomaterial after overnight treatment within multivesicular bodies which have been associated with endosomal trafficking 
events by confocal microscopy. Moreover, this approach allows assessing the cellular response towards the treatment by 
evaluating the morphological changes induced. This is especially relevant for the future usage of nanoformulations in clinical 
practices. This correlative super-resolution and X-ray imaging strategy joins high specificity, by the use of fluorescence, with 
high spatial resolution at 30 nm (half pitch) provided by cryo-SXT in whole cells, without the need of staining or fixation, and 
can be of particular benefit to locate specific molecules in the native cellular environment in bio-nanomedicine.
Introduction
The intracellular localization of specific therapeutic agents is a 
mandatory step towards understanding their mechanisms of 
action and effects at the cellular level. To this aim, a correlative 
imaging approach, which delivers information on the cellular 
ultrastructure and the molecular localization in whole cells 
under close-to-native conditions, is compulsory. An 
unambiguous molecular localization will allow, firstly, to 
understand what possible routes are used to enter the cell, 
secondly, how the cell deals with a specific agent, and finally 
what are the effects induced by the treatment on the 
ultrastructural morphology, which is a direct reflection of the 
cellular homeostasis.1 Here we use a novel 3D cryo correlative 
light and X-ray tomography (CLXT) imaging approach, the 
protocol of which is described elsewhere2, towards the 
investigation of a promising antifibrotic treatment for 
myocardial fibrosis as a model system. CLXT utilizes the gold 
standard for sample preparation of cryo-preserved cells, and 
combines 3D structured illumination microscopy (cryo-3D-SIM) 
to locate the therapeutic agent through its fluorescence signal, 
followed by soft X-ray tomography (cryo-SXT) to visualize this 
specific fluorescence signal in the cell ultrastructural context 
pinpointing its fate in the whole 3D cellular environment. This 
novel methodology is not only high-throughput, allowing 
imaging of cell populations at different conditions and time 
points, but it also benefits from the broad range of existing 
fluorescent dyes and proteins, opening its use to a wide range 
of biological studies.
This work focuses on the particular example of cardiac fibrosis, 
a health condition that negatively influences the progression of 
many heart diseases and affects millions of people worldwide.3 
Regardless of the etiology of the cardiac injury, cardiac fibrosis 
promotes the pathological increase of collagen deposition 
leading to heightened myocardial stiffness and dampened 
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cardiac function, which are common features in patients with 
advanced cardiac failure.4 There is no preventive or curative 
treatment for cardiac fibrosis, due to the elusive mechanism of 
fibrosis and the lack of specific targets.5 Although a number of 
therapeutic agents prescribed for specific cardiovascular 
disorders have been shown to exert beneficial effects on 
myocardial fibrosis, in most cases an invasive surgery to save 
the patients live is needed.3 The transforming growth factor β 
(TGF-β) is a cytokine that triggers the activation of myocardial 
fibroblasts, regulating collagen production and deposition in 
the extracellular matrix.6 Together with the heat shock protein 
90 (Hsp90), they participate in the pro-fibrotic signaling cascade 
promoting cardiac fibrosis.7 Transforming growth factor β (TGF-
β) is a cytokine that triggers fibroblast activation, regulating 
collagen production and deposition in the extracellular matrix. 
Heat shock protein 90 (Hsp90), participates in the pro-fibrotic 
signaling cascade triggered by TGF-β promoting cardiac 
fibrosis.7 TGF-β is an essential cytokine excreted by many cell-
types and involved in many important functional processes such 
as regulation of immune reaction, control of differentiation, 
regulation of proliferation and participation in inflammation 
among others.8 Due to these pleiotropic effects, in vivo TGF-β 
targeting to reduce fibrosis is always accompanied by a large 
number of side effects. As a result, a possible strategy to reduce 
fibrosis while avoiding side effects is the inhibition of a key 
factor involved in its profibrotic signaling cascade, such as 
Hsp90, which has been shown to play an essential role in TGF-
β-mediated collagen production.9
The development of an engineered Hsp90 inhibiting module 
(CTPR390) based on a tetratricopeptide repeat (TPR) domain 
has shown great potential inhibiting Hsp90.10–12 In particular, 
previous studies have demonstrated its effectiveness to reduce 
myocardial pro-fibrotic events in vitro and in vivo.12 Further 
studies focused on re-engineering the Hsp90 inhibitory domain 
by its fusion to a related TPR domain that enables the 
stabilization of a metallic nanocluster, in this case a gold 
nanocluster (AuNC).13 This engineered protein-nanomaterial 
hybrid (Prot-NM) also showed efficient therapeutic activity by 
reducing the myocardial fibrosis and heart hypertrophy in an 
animal model of cardiac remodeling.14 In addition, the AuNC has 
shown to exhibit fluorescence (λexc = 370/ λem = 445 nm)13, 
which can be used for localization, and it has shown to have a 
positive effect on the internalization of the Prot-NM.14 Herein, 
we have further investigated its in vitro localization and effect 
by looking at the cellular response at the ultrastructural level, 
testing both primary cardiac mouse fibroblast and the NIH-3T3 
immortalized embryonic fibroblasts. We aim at unravelling the 
cellular effects of this promising therapeutic agent, and expect 
to directly correlate those effects with the Hsp90 inhibition. For 
this aim, we treated the fibroblasts with two protein hybrid 
systems, with and without the engineered Hsp90 inhibitory 
domain (TPR-Hsp90-AuNC and TPR-AuNC, respectively). Then, 
the treated fibroblasts were cryopreserved and imaged using 
CLXT.2 Furthermore, these results were complemented by 
confocal microscopy.
Cryo-3D-SIM at B24 beamline (Diamond Synchrotron, UK)15 was 
used to locate the Prot-NM in the cellular environment. Due to 
a sub-optimal laser excitation wavelength (405 nm) for the 
AuNC, resulting in low fluorescent emission, the Prot-NM was 
tagged with the fluorophore Alexa-488 (see S1). Furthermore, 
to position the fluorescent signal in the context of the full 
cellular structure, cryo-SXT16,17 in the water window energy 
range was subsequently used18–26 at the Mistral beamline (Alba 
Synchrotron, Spain).27,28 The data collected with cryo-SXT was 
in addition used to obtain valuable information about specific 
organelle morphology and number which are an indication of 
cellular homeostasis.1 Indeed, the mitochondrial homeostasis in 
healthy cells is maintained through dynamic and tightly 
regulated fission and fusion events. Therefore, a change in the 
mitochondrial morphology and number gives insights into the 
overall health of the cell.29
The combination of cryo-3D-SIM and cryo-SXT is a novel and 
powerful correlative imaging approach15,30 which enables 
linking cellular function and structure with high spatial 
resolution in close-to-native conditions. Both techniques are 
high throughput and easy to use (e.g. same sample support and 
no intensive sample preparation needed) although 3D data 
correlation requires a proper fiducialisation strategy.2 Note that 
a full workflow in cryogenic conditions maximizes efficiency by 
maintaining sample integrity and quality between the 
microscopy modalities. 
Herein, we investigated the intracellular fate of these two Prot-
NM, with and without the Hsp90 binding domain, accurately 
locating them within specific cellular organelles while 
describing related clear morphological effects which have been 
found to be cell type-dependent, concluding that primary 
mouse fibroblast are more resilient to the treatment with the 
Prot-NM than NIH-3T3 cells.
Results
Cryo-3D-SIM confirms the presence of the protein nanomaterial 
hybrid in treated cells.
CLXT was used to image four groups of both primary cardiac 
mouse fibroblasts and NIH-3T3 cells: the control group, TGF-β 
activated group, TGF-β activated and treated with TPR-Hsp90-
AuNC (TPR-Hsp90-AuNC group), and finally TGF-β activated and 
treated with the TPR-AuNC, lacking the Hsp90 inhibitory domain 
(TPR-AuNC group). Comparing previous studies, it became 
apparent that the presence of the metal cluster on the Prot-NM 
has a positive effect on the internalization and the final 
therapeutic effect of the Hsp90 inhibitory activity.12–14 
Considering this, only hybrid formulations with AuNCs were 
selected for evaluation.
In the case of the TPR-Hsp90-AuNC group, the Alexa-488 
specific signal was intense and well-defined in specific 
intracellular locations, confirming that the observed 
fluorescence signal corresponded indeed to the internalized 
TPR-Hsp90-AuNC as no equivalent signal was found in the other 
groups. Nonetheless, some low intensity auto-fluorescence 
signal was observed in the control and the TGF-β groups at both 
excitation wavelengths (405 nm and 488 nm) (see S1, S2 and 
S3). In the case of the TPR-AuNC group a low but distinct signal 
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was found (S2 and S3) indicating the presence of TPR-AuNC at 
significantly lower concentrations than TPR-Hsp90-AuNC in the 
cell. The comparison of the maximum fluorescence signal value 
collected between the treatment groups showed a slight 
increase of TPR-AuNC signal compared to the autofluorescence 
signal of the control (2-fold) and TGF-β (1.5-fold), and a 6-fold 
increase in value for the TPR-Hsp90-AuNC compared to the TPR-
AuNC (see S3). After cryo-3D-SIM imaging, cryo-SXT was 
performed on the same cells at the Mistral beamline (Figure 1).
Cryo-SXT provides ultrastructural information of the cell and 
places the fluorescence signal unambiguously within 
multivesicular bodies.
Figure 1 presents the correlated data of a TPR-Hsp90-AuNC 
treated NIH-3T3 cell. Figure 1A shows the 2D X-ray projection 
mosaic (i.e. tile-scanned projections covering a grid square) of 
the full cell and figure 1B its overlay with the 2D SIM data 
projection. The red fluorescence signal corresponds to the 
mitotracker Red CMXRos (ThermoFisher) and the green to the 
Alexa488-labelled TPR-Hsp90-AuNC. For this cell, five areas 
within the cytoplasm surrounding the nucleus were chosen for 
tomography collection, and a single slice of the resulting 
combined reconstructions is shown in figure 1C, superimposed 
on top of the X-ray 2D mosaic. In figure 1D a single slice from 
the correlated 3D datasets is shown (see S4 for the correlation 
accuracy map and for a video of the whole 3D stack). No laser 
damage was noticed at the achievable resolution of cryo-SXT 
(30 nm half pitch according to the FSCe/o criterion, see S5)19,31–
33 after cryo-3D-SIM. Correlating both 3D datasets, the TPR-
Hsp90-AuNC signal was unambiguously located in 
multivesicular bodies (MVB) which were homogenous in size 
(0.5 - 1 μm in diameter) and distributed throughout the 
cytoplasm (Figures 1B, 1D and Figure 2). The calculated 
correlation accuracy map shows an accuracy down to 70 nm 
although this will vary within the volume region and depends 
directly on the fiducialisation strategy chosen14 as shown in S4. 
These MVBs showed vesicle-like compartments with different 
morphology and higher linear absorption coefficient in the case 
of primary mouse fibroblasts, which might indicate a different 
mechanism of processing this TPR-Hsp90-AuNC accumulation 
by the cell (see Figure 1 bottom and S6 for additional 
information on MVB morphologies in both cell types). Note that 
cryo-SXT directly reconstructs the linear absorption coefficient 
value of the elemental composition within each voxel; hence 
being quantitative and therefore allowing direct comparison.24 
In order to evaluate the number and size of MVBs observed 
upon the different treatments, we segmented the volumes 
using Amira software34 (see Figure 4). Even though no direct 
comparison can be made between cell types due to the larger 
size of the primary cells compared to NIH-3T3, the appearance 
and tendencies observed in the two can be compared. When 
evaluating the TGF-β-treated groups, both cell types seem very 
similar to the control group, having an almost identical average 
and slightly decreased median MVB volume, the latter being 
more evident in NIH-3T3 than in primary fibroblasts. This result 
suggests that these MVBs are part of a normal cell function and 
not related or affected by stress-induction. In the case of cells 
treated with TPR-Hsp90-AuNC, a large increase in MVB number 
was found with respect to the control group (85% increase for 
NIH-3T3 and 74% for primary mouse fibroblasts, see Figure 4). 
When focusing on the primary fibroblasts a non-significant 
decreased volume was observed. Together with the increase in 
MVB number, these results suggest the recent formation of new 
vesicles upon the treatments. Regarding the NIH-3T3 cells, the 
vesicles present an increase in volume, although non-
significant, suggesting that these vesicles were formed early 
after incorporation of the therapeutic agent and matured by the 
time of vitrification. Lastly, the samples treated with TPR-AuNC 
showed a slight increase in the number of MVBs compared to 
the untreated control (29% for NIH-3T3 and 11% for primary 
fibroblasts) and TGF-β treated cells, although not significant as 
overall numbers are very low. However, in both cell types this 
group presented the significantly smallest average and median 
volume for the MVBs (t ≤ 0.05 for NIH-3T3 and t ≤ 0.01 for 
primary fibroblasts). Ultimately, with the exception of the TPR-
Hsp90-AuNC samples, the MVBs evaluated in both cell types 
were very similar when the same treatment is compared.
Confocal microscopy reveals the nature of the organelle 
containing the therapeutic agent.
To determine which type of vesicles contains the TPR-Hsp90-
AuNCs and understand their role, different biomarkers were 
tested to evaluate their spatial association with the Alexa488 
signal. The selected targets were: Alix, Flotillin-1, CD9 and LC3-
II, all associated to different types of cellular vesicle as explained 
below. All assays were performed on cells fixed with 
paraformaldehyde (PFA) and imaged by confocal microscopy.
Figure 3 shows the comparison of the co-localization of Alix 
(Figure 2A and 2B), Flotillin-1 (Figure 2C and 2D), and CD-9 
(Figure 2E and 2F) with TPR-Hsp90-AuNC in NIH-3T3 and 
primary fibroblasts. Both anti-Alix and anti-Flotillin-1 are 
markers for MVB biogenesis while anti-CD9 (anti-tetraspanin 
CD9) is associated with adhesion, motility, membrane fusion, 
signal trafficking vesicles and cargo transfer from cellular 
vesicles.35,36 In NIH-3T3 cells a spatial co-localization (at the 
achievable confocal resolution) of TPR-Hsp90-AuNC with anti-
Alix and anti-CD9 was observed. In addition, low anti-Flotillin-1 
signal was detected and there was no spatial association with 
the therapeutic molecule. In the case of primary mouse 
fibroblasts, some spatial association was observed with anti-
Alix, although the signal was lower compared to the NIH-3T3 
cells. Similar to NIH-3T3, some signal was detected from anti-
Flotillin-1, although it appeared diffused. Finally, some foci were 
observed from the anti-CD9, but there was no association with 
the TPR-Hsp90-AuNC. With the above observations, the two cell 
types appear to show the same tendency with the exception of 
CD9 biomarker that showed co-localization with TPR-Hsp90-
AuNC in NIH-3T3 and not in primary fibroblasts.
These biomarkers were also tested upon TPR-AuNC treatment 
(S7). The TPR-AuNC group showed the same associations with 
anti-Alix for both cell types and a co-localization with anti-CD9 
in NIH-3T3, however none in primary fibroblasts similarly to 
TPR-Hsp90-AuNC. Moreover, and contrary to TPR-Hsp90-AuNC, 
a clear spatial association between Flotillin-1 and TPR-AuNC 
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was observed, especially in primary fibroblasts. Few foci were 
also observed in NIH-3T3 cells. 
The last biomarker, anti-LC3-II, was chosen to test for 
autophagy and degradation via autophagosomes (S8). A small 
number of foci were detected in both cell types for both 
treatments; however, only in NIH-3T3 cells treated with TPR-
AuNC an association was observed. Overall, these results ruled 
out the conjecture that TPR-Hsp90-AuNC-containing MVBs 
were involved in the autophagosome pathway. The possibility 
of an enhancement of programmed cell-death apoptotic events 
caused by stress upon treatment was also tested using the 
activated caspase-3 (cleaved caspase-3 Asp175).37 No 
increments were seen for TPR-AuNC, TPR-Hsp90-AuNC, nor 
TGF-β treated cells, which indicate that TGF-β is not inducing 
apoptosis at the concentration used in this study. Moreover, the 
control cells were also labelled and imaged and showed no foci 
with any of the tested biomarkers (S9).
Cryo-SXT enables a statistical analysis of the observed 
morphological differences upon treatment.
In addition to elucidating the intracellular fate of the Prot-NM, 
cryo-SXT allowed evaluating possible changes in the cellular 
ultrastructure upon treatment (Figure 3). Of special interest was 
the mitochondrial morphology as their appearance is directly 
related to the cellular health, as already mentioned. In order to 
obtain statistical information about morphological changes of 
the different cell groups and to understand the effect of the 
treatment, the mitochondria were also segmented using Amira 
software.34 This segmentation allowed evaluating the number, 
volume and shape dependence of these organelles for each 
treatment with respect to the control cells.
In the case of the NIH-3T3 cells, the TGF-β group presented an 
increased number of mitochondria (78% more compared to the 
control) with smaller volume and increased elongation (see 
Figure 3 and Figure 5). This indicates that the cells are both 
increasing their mitochondria surface area and are producing 
more mitochondria for upcoming changes. Previous work 
showed that treatment with TGF-β leads to differentiation or 
activation of the cell to increase collagen production38, being 
both very energy consuming processes. This confirms that the 
TGF-β treatment is promoting the desired cellular pro-fibrotic 
events and that the changed mitochondrial morphology is a 
natural reaction to the activation with TGF-β. The TPR-Hsp90-
AuNC group showed a smaller number of mitochondria (44% 
less compared to the control) with increased volume. This type 
of mitochondrial swelling is usually associated to cellular 
stress.39 In the case of TPR-AuNC, a similar effect on the cells 
than for the TGF-β group was expected. Indeed, similar 
mitochondrial volume but with a slight increase in the number 
of mitochondria (20%) was observed. However, the 
mitochondrial elongation present in the TGF-β group was not 
observed. 
When analyzing the cardiac primary mouse fibroblast, 
significant differences compared to the NIH-3T3 cells were 
observed (see Figure 3 and Figure 5). First, the number of 
mitochondria was similar in all four groups (see Figure 5), 
although a decrease of 20% compared to the control is found in 
the TPR-Hsp90-AuNC group, following the same tendency than 
for NIH-3T3. Second, the mitochondria volume was also similar 
for all the groups except the TGF-β one which showed a 
significantly higher mean volume compared to the control. This 
can be explained by the increased energy demand, similar to the 
observed effect in NIH-3T3 cells. In terms of sphericity, there 
were significant differences between most of the groups. 
Contrary to what was seen in the NIH-3T3 cells, the control 
group had the most diverse shapes consistent with the 
expected continuous fission and fusion of mitochondria.29 For 
both TGF-β and the TPR-AuNC groups, mitochondria appeared 
rather spherical, while the TPR-Hsp90-AuNC group showed 
slightly greater variety of shapes, but still leaning towards 
spherical mitochondria. Mitochondria morphological changes 
due to fission and fusion are beneficial under conditions of high-
energy demand40 as in the case of TGF-β induced collagen 
production in fibroblasts. Note that apart from the control, all 
groups have been ‘activated’ with TGF-β and therefore higher 
mitochondrial activity demand was expected.
Even though no direct comparison of the numbers between cell 
types can be done, as primary mouse fibroblasts are larger than 
NIH-3T3 cells, tendencies and the mitochondria appearance can 
be compared. Primary mouse fibroblasts seemed overall more 
stable, as no large divergence from the control was measured, 
although a significant reaction towards the activation with TGF-
β was observed. On the contrary, each treatment in NIH-3T3 
cells causes a unique and seemingly extreme reaction. A 
significant reduction in mitochondrial size combined with 
increased number suggests mitochondrial fission events, which 
play a critical role in the attenuation of mitochondrial damage.41 
In addition, the presence of many small, rounded mitochondria 
points to a stationary phase of the cell with low activity.42 These 
findings already suggest that the NIH-3T3 cells experience more 
difficulties when dealing with a sudden change in cellular 
homeostasis, as in this case of the TGF-β activation. 
Furthermore, the mitochondrial swelling observed in the TPR-
Hsp90-AuNC groups, which is a clear indicator for oxidative 
stress43, supports this hypothesis. These results demonstrate 
that primary mouse fibroblasts are more resilient to an altered 
cellular homeostasis which is in this case induced by both TGF-
β and the nanomaterial treatment compared to the 
immortalized embryonic NIH-3T3 fibroblasts.
It is worth mentioning that no structural changes have been 
observed in the cell nuclei, lipid droplets or vacuole numbers 
whereas in the case of the ER, some opening was observed in 
the groups treated with either Prot-NM for both cell types with 
respect to their control cells. This type of ER enlargement is 
normal in cardiac fibroblasts in which fibrosis events have been 
triggered, as is also stimulated with the TGF-β treatment. This 
effect was already shown previously12 and was here confirmed. 
However, in the NIH-3T3 TPR-AuNC group this effect appeared 
even larger than for the TGF-β group (Figure 3). 
Finally, in order to confirm the findings of previous studies12 
that this Prot-NM can indeed inhibit collagen production, NIH-
3T3 cells were incubated for 48 h applying the same treatment 
groups and imaged. Note that, to this aim, tomograms were 
collected in extracellular areas between cells, where collagen 























































































































Journal Name  ARTICLE
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 5
Please do not adjust margins
Please do not adjust margins
bundles are expected. As was previously described for a similar 
Hsp90 inhibitory molecule (CTPR390-488)12, some collagen 
fibers were found in the TPR-Hsp90-AuNC group. However, 
these fibers seemed less structured and in lower quantity than 
for the TGF-β group, which presented clearly defined collagen 
bundles as expected (see S10). Therefore, a complete inhibition 
of extracellular collagen production in NIH-3T3 cells was not 
achieved upon treatment, but a substantial reduction was 
indeed visible.
Discussion
Alix is an accessory protein of the endosomal sorting complex 
required for transport and has been related to the biogenesis of 
trafficking vesicles, such as extracellular vesicles.44 The cellular 
trafficking-related protein Flotillin-145 has been related to 
endocytosis and endosomal trafficking events. In addition, lipid 
raft-dependent endocytosis can be mediated by Flotillin-1 that 
would be recruited to the surface forming pre-endocytic 
clusters.45 TPR-Hsp90-AuNC did not show co-localization with 
Flotillin-1, while TPR-AuNC did. The lack of association for the 
first could suggest that the protein hybrid does not enter via 
endocytosis. The ability of TPR-Hsp90-AuNC to bind to 
extracellular Hsp9012 may allow it to enter the cell bound to this 
chaperone through a different route than TPR-AuNC. This 
mechanism would also explain the lower intracellular 
concentration of TPR-AuNC as an active transport via Hsp90 
naturally results in higher intracellular concentrations 
compared to a passive, endocytosis-dependent incorporation. 
After uptake of the nanomaterials, trafficking vesicles 
presenting Alix, which showed association with both Prot-NM, 
could then be the main transport route. The difference 
concerning the association with CD9 for both nanomaterials, 
observed only in NIH-3T3 cells, can be related to exocytosis 
events and may suggest a different cell-dependent way of 
dealing with the Prot-NM. This hypothesis is in line with our 
observation of an increased absorbance of the MVBs in primary 
fibroblasts compared to NIH-3T3 cells (Figure 1 bottom and S6) 
by cryo-SXT. Overall, these results suggest that the MVBs are 
mainly related to endosomal trafficking events, however the 
origin of the endosomal trafficking seems to differ depending, 
not only on cell type, but also on the presence of the Hsp90 
binding module. 
Cryo-SXT allowed us to draw conclusions regarding the reaction 
of the cell towards the treatment. The immortalized NIH-3T3 
fibroblasts showed clear signs of stress in the form of 
mitochondrial swelling, likely due to the TPR-Hsp90-AuNC 
treatment. This swelling event was not observed for TPR-AuNC, 
which suggests a direct link between the molecular changes 
promoted by the binding of the hybrid functional protein to the 
C-terminal end of Hsp9014, although the lower uptake could also 
explain this lack of visible swelling. Other studies have already 
reported that stress, especially oxidative stress, induces 
mitochondrial swelling, which would support our first 
hypothesis.43 Whether the stress is induced only by the Hsp90 
inhibition46,47 or also because of the presence of the AuNC48,49 
is therefore still to be answered. 
Both cell types were affected by a low intracellular TPR-AuNC 
concentration, as shown by the morphological differences in 
mitochondria shape and number, as well as in the extra ER 
enlargement, especially in NIH-3T3 cells. This type of ER 
enlargement is normal in cardiac fibroblasts in which fibrosis 
events have been triggered as shown previously12 and 
confirmed here. Nonetheless, the fact that TPR-AuNC treatment 
has a noticeable effect on the cells, while missing the Hsp90 
inhibitory domain, suggests that the observed effect for the 
NIH-3T3 TPR-Hsp90-AuNC group is probably not entirely due to 
the Hsp90 inhibition. These effects could stem from the AuNC, 
the metallic component of the Prot-NM as was suggested 
before. Note that the increased Hsp90 production is not the 
only effect induced by the TGF-β activation. Another possibility 
could therefore be related to a different signaling cascade 
induced by the TGF-β. This hypothesis is supported by our 
observation in the TGF-β group, which showed a drastic 
morphological change compared to the control group. 
Ultimately, more research will be needed to investigate these 
observations and to determine which aspect of the treatment is 
causing the morphological changes observed. Finally, it is worth 
mentioning that these results reinforce the need of evaluating 
systematically the cellular structure upon application of specific 
treatments with adequate imaging techniques to be able to 
assess the cellular response.
Primary mouse fibroblasts, on the other hand, do not exhibit 
these symptoms of stress after overnight TPR-Hsp90-AuNC 
treatment, indicating that the cells had time to recover or adapt 
to the new conditions. The fact that the number of 
mitochondria is similar in every group, is in line with other work 
that related organelle size to cellular homeostasis1, arguing that 
every cell type has an optimum number of organelles and a 
deviation from this number suggests a change in gene 
expression. While previous studies12–14 already highlighted the 
lack of negative effects, we now confirm that at the 
ultrastructural level TPR-Hsp90-AuNC is a viable option to 
inhibit the Hsp90 protein in primary mouse fibroblasts while 
also ensuring its ATPase activity and thereby keeping the cell in 
homeostasis. Despite the side effects in NIH-3T3 cells, we 
confirm here that Hsp90 inhibition at the C-terminal end 
reduces collagen overproduction in both cell types. 
Methods
TPR preparation. 
The TPR variants used in this work have been previously 
described.11,14 The His-tagged proteins have been purified by 
affinity chromatography following standard protocols. C41 
(DE3) cells transfected with the pProEx-HTA plasmid encoding 
the desired TPR gene, were grown in an orbital shaker at 37ºC 
to an optical density of 0.6-0.8. Then the protein expression was 
induced with 1 mM isopropyl β-d-thiogalactoside (IPTG) and the 
cell were left for 16 hours at 20ºC. The cells were centrifuged 
and lysed by sonication in 50 mM Tris, 500 mM NaCl, pH 8.0. 
Proteins were purified from the supernatant using a 5 mL 
HisTrap Q column (GE Healthcare). Then, the his-tag was 
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removed by TEV protease cleavage and purified by gel filtration 
chromatography (HiLoad 16/60 Superdex 200 column).
AuNC formation. 
AuNCs were synthesized and stabilized in the protein scaffolds 
using a protocol based on previously reported procedures.13,14 
A protein at 20 µM was incubated with HAuCl4 (30 eq. with 
respect to protein) for 1 hour at 20 ºC. After, a reduction step is 
applied by adding 100 eq. with respect to the Au concentration 
of sodium ascorbate and left to incubate at 50 °C for 72 h. 
Finally, the Prot-NM were purified by gel filtration (Sephadex G-
25 column). 
Alexa labeling. 
Alexa Fluor 488 NHS ester was used to label the TPR-Hsp90-
AuNC and TPR-AuNC proteins through their primary amines at 
a 1:2 stoichiometry to avoid over-labeling and potential 
disruption of the protein recognition activity.
Primary mouse fibroblasts isolation. 
Live animal studies were approved by the University of 
Cantabria (Spain) Institutional Laboratory Animal Care and Use 
Committee in compliance with the Guide for the Care and Use 
of Laboratory Animals (ILAR, 1985) and were conducted in 
accordance with the “European Directive for the Protection of 
Vertebrate Animals Used for Experimental and Other Scientific 
Purposes” (European Communities Council Directive 
86/606/EEC).
Adult cardiac fibroblasts from mice C57BL6 strain (wildtype) 
were isolated directly from enzymatically digested hearts 
(collagenase, trypsin and DNase) followed by centrifugation and 
filtration. They were maintained in Dulbecco's Modified Eagle's 
Medium (DMEM) containing 10% FBS and 100 U/ml penicillin-
streptomycin. The cells (2×105) were plated in 35 mm cell 
culture dishes incubated at 37°C in 5% CO2. For experimental 
procedures, low passage cells (p2) were seeded onto 60 mm cell 
culture dishes.
Sample preparation for CLXT. 
The sample preparation protocol is based on a previously 
published procedure2,50 and involves cryogenic liquids. Both 
NIH-3T3 and primary myocardial mouse fibroblasts were grown 
in complete culture medium (DMEM with 10% FBS and 1% 
Penicilin/ Streptomycin) at 37 °C and 5% CO2 until a confluence 
of 70-80% was reached. At this point the cells are ready for 
subculture, or for sample preparation. As sample support, gold 
quantifoil R 2/2 holey carbon-film microscopy grids (Au-
G200F1) were used. Before cell deposition, grids were placed in 
P60 Petri-dishes, already separated by type of treatment, and 
UV-sterilized. Spreading the grids at this stage minimizes grid 
handling and possible damaging. Cells are washed in PBS and 
seeded on top of the grids at a concentration of around 2-3 x105 
cells per ml (3 ml total in the case of a P60 Petri dish). After 
allowing the cells to settle and get accustomed to the surface 
for around 24 hours, they were treated. Both the NIH-3T3 and 
primary fibroblasts were divided in 4 groups: control, TGF-β 
activated, TGF-β activated and treated with TPR-Hsp90-AuNC, 
and lastly TGF β activated and treated with TPR-AuNC, lacking 
the Hsp90 inhibitory domain. Cells were activated with 1 ng/ml 
TGF-β final concentration and for the TPR-Hsp90-AuNC, as well 
as TPR-AuNC groups, the activated cells were treated with their 
respective Prot-NM at a final concentration of 0.8 μM. Note that 
the concentration of TGF-β to activate the cells, was increased 
compared to the previous study (by 3 times)12. This increase 
provided a more consistent response of the cell population 
without affecting the gene-expression on a single cell basis 
(data not shown). After overnight incubation, Mitotracker Red 
CMXRos (ThermoFisher) was added to the grids, following 
manufacturer recommendations. After the incubation time of 
the fluorescent dye has passed, a mix of 100 nm gold fiducial 
markers (BBI Solutions; 10x concentrated) and 200 nm 
Tetraspecks (ThermoFisher; 5x diluted) was prepared and 3 μl 
thereof was deposited on the grid followed by blotting of 2 s 
using a Whatman #1 filterpaper and vitrification through plunge 
freezing in liquid ethane precooled by liquid nitrogen in a Leica 
EM-CPC. Care has to be taken as grids have to be kept at 
cryogenic temperatures from this point on at all times. Pre-
screening of the vitrified grids was done using a Linkam CMS196 
cryo-stage on a Zeiss Axio Scope fluorescence microscope to 
determine the integrity of the grid as well as pinpointing cells of 
interest. A selection of grids is made at this point for correlative 
workflow.
Cryo-3D-SIM.
The selected grids, at least two per cell and condition, were sent 
to B24 at the Diamond Synchrotron (UK). The grids were imaged 
with their home-build cryo-3D-SIM51 to collect the green signal 
coming from the Alexa488 on the TPR proteins (λexc 488/ λem 
525, 40 mW, 100 ms), and red signal coming from mitotracker 
Red CMXRos (λexc 561/ λem 605, 40 mW, 50-100 ms depending 
on staining efficiency) using a 100X 0.9 NA objective lens 
achieving a lateral resolution of roughly 210 nm full width at half 
maximum (FWHM) at an emission wavelength of 488 nm.15 For 
each sample-type three to six cells, preferably from different 
grids, were imaged and the collected data was processed on 
site. 
Cryo soft X-ray tomography. 
The grids were then sent back to Mistral at ALBA (Spain) for data 
collection using soft X-ray microscopy.27,28,50 The grids were 
loaded into the transmission X-ray microscope (TXM) chamber 
and the cells imaged prior with the cryo-3D-SIM were identified 
using the on-line visible light fluorescence microscope inside 
the TXM vacuum vessel with a long distance 20X objective. Once 
the areas were found again, tilt series were collected at a 
photon energy of 520 eV in areas showing interesting 
fluorescence signal in the cryo-3D-SIM data. In addition, other 
cells were imaged for morphological data evaluation, 
comparison and statistics. All data was collected using a Ni 
Fresnel zone plate lens with an outermost zone width of 25 nm 
(courtesy of S. Rebhein, HZB-Bessy II), giving an effective voxel 
size of 10 nm3. Depending on the sample and the position of the 
cell on the grid, images were collected covering a maximum 
angular range of -65° to +65° (or less) with a constant step size 
of 1°. While for the lower tilt angles an exposure time of 1-2 
seconds was used, at higher tilt angles the exposure time was 
increased up to 4 seconds, to increase the signal-to-noise ratio 
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while taking care to not oversaturate the CCD camera. The data 
was then pre-processed by normalization with the collected 
flatfield signal (flux impinging the sample) and the 
corresponding machine current, followed by deconvolution of 
the measured PSF of the TXM at the corresponding energy.31
Fluorescence and immunofluorescence assays. 
The immunofluorescence assays of Hsp90 were performed 
using the aforementioned treatments. Then samples were fixed 
(4% paraformaldehyde), permeabilized (20-30 min 
0.05%Triton-X in PBS 1x) and incubated overnight at 4ºC with 
different primary antibodies anti-Alix (1:100, sc53540), anti-
Flotillin-1 (1:100, sc74566), antiCD9 (1:100, donation from 
Sanchez-Madrid), anti-LC3-II (Cell Signaling #2775) and anti-
caspase-2 (ab182657). The samples were washed with 0.05% 
Tween 20 in PBS, incubated for 30 min in the specific secondary 
antibody conjugated with Alexa-568 (ThermoFisher), washed in 
PBS and mounted with the Vectashield antifade mounting 
medium (Vector).
Confocal images were obtained in the microscopy facility 
(IDIVAL, Santander, Spain) with a confocal microscope NIKON 
A1R spectral (405nm, 488nm, 514nm, 561nm, 638nm) and Fiji52 
was used for data visualization. 
Data processing. 
The tilt-series were aligned using the 100 nm Au fiducials and 
the IMOD software.53 The reconstruction was performed using 
the SIRT algorithm54 with tomo3d with long object 
compensation55 for a fast reconstruction, which is for 
visualization purposes only, or using the ART algorithm56 with 
tomoJ57 for linear absorption coefficients recovery. The 
tomographic reconstruction of each of the cells (several 
tomograms per cell collected) imaged before using the cryo-3D-
SIM were then post-processed using Fiji52 to ensure they are 
aligned to each other by flattening and cropping in the z-
direction to adjust the height, based on the carbon quantifoil 
support layer. The correlation was done using the ICY58 plugin 
in ecCLEM.59 First, the cryo-SXT reconstructions were 2D 
transformed to the X-ray mosaic to place them in the context of 
the whole cell as each tomogram covers a volume of 10 µm3 of 
the cell. To prevent excessively large files, cropping of the X-ray 
mosaic to the area containing the reconstructions is performed. 
The transformed files could then be combined into one for 
subsequent 3D correlation. Because of the chromatic shift of 
the 3D-SIM, the fluorescent channels were first aligned to each 
other using the 200 nm Tetraspecks. After this, the now aligned 
fluorescent channels were roughly transformed in 2D to the X-
ray mosaic using large feature, like for example the holes in the 
quantifoil film or using large organelles, like mitochondria. After 
this the fluorescent data was transformed in 3D using more fine 
features such as Tetraspecks or recognizable organelle shapes. 
Statistical Analysis of organelles. 
The tomographic reconstructions were segmented using Amira 
software.34 Measurements of the segmentation were 
performed using the Amira module Label Analysis. For the 
volume, the native measure is used but for the sphericity a 








with V being the volume of the label and A being the surface 
area. For each condition four tomographic reconstructions 
belonging to four different cells were segmented and 
measured. The statistical analysis was performed using Excel 
2016s Data Analysis add-in. First, the datasets were tested for 
equal or unequal variance, followed by the corresponding two-
tailed t-test using a cut-off value of 0.05 to test for significance 
between the groups.
Conclusions
Herein, CLXT has allowed locating unambiguously and in the 3D 
cellular environment, a designed therapeutic agent inhibiting 
Hsp90 after being internalized by two different types of 
fibroblasts. Furthermore, this novel methodology enables 
evaluating the effects of the different treatments at the cellular 
level which is essential for a future practical usage at the clinical 
level. Cryo-3D-SIM provides excellent specificity using a wide 
range of common dyes and fluorescent proteins and adequate 
3D resolution for correlative purposes, although higher 
sensitivity at the single molecule level and resolution would be 
desirable. Cryo-SXT in turn reveals the environmental context 
and the ultrastructural detail, which allows identifying the 
designed protein nanomaterial hybrid (Prot-NM) containing 
organelles and describing the morphological differences 
accompanying the different treatments. In both cases, the TPR-
AuNC with and without Hsp90 binding module were found in 
specific multivesicular bodies (MVBs), although in higher 
numbers in the first case. These MVBs likely play a functional 
role in cell homeostasis. Furthermore, we found substantial 
differences between NIH-3T3 and primary mouse fibroblast 
cells, which led us to conclude that the immortalized version of 
a cell type may not always be a good functional alternative 
when studying molecular processes as deviations from primary 
cells can occur.
This detailed study, using correlatively cryo-3D-SIM and cryo-
SXT to obtain specific intracellular location and ultrastructural 
information, highlights the relevance of a mechanistic 
understanding of the molecular process triggered by novel 
engineered Prot-NM with potential therapeutic applications. 
Here, a protein engineering-based biological drug (TPR-Hsp90-
AuNC) with a demonstrated effect as antifibrotic molecule has 
been evaluated. The results of this study reveal the effect of the 
Hsp90 inhibitory domain and its correlation with its antifibrotic 
function and mechanism. But at the same time, they show that 
the presence of a small metallic nanocluster of 4 to 12 atoms, in 
addition to its function as a stabilizing and tagging module, 
possibly has an effect on the cellular morphology, which still 
needs to be investigated further for a complete understanding. 
It is important to note that, considering the modularity of the 
engineered system, the inhibitory domain is interchangeable. 
This opens up possibilities for a wide variety of treatments that 
could benefit from the design of alternative Prot-NM. As has 
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been shown here, CLXT is able to track the fate of the specific 
therapeutic agent with high correlation accuracy, as well as 
monitor with statistical significance the morphological changes 
due to the treatment, allowing shedding light on the cellular 
processes triggered. The methodology utilized is applicable to 
other disease models and systems and will always provide 
excellent specificity and spatial resolution. These latest results 
put the focus on the need to study the effects of nanomaterials 
at the cellular level in close-to-native conditions in order to be 
able to further propel nanomaterial-based drugs and 
nanomedicine into the clinic.
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Correlation of a TPR-Hsp90-AuNC treated NIH-3T3 cell using cryo-3D-SIM showing the mitochondria in red 
(CMXRos mitotracker) and the TPR-Hsp90-AuNC in green (Alexa-488) and cryo-SXT showing the 
reconstructed linear absorption coefficient. A: X-ray projection mosaic; B: cryo-SIM signal projection 
overlaid on X-ray mosaic; C: single slice of the tomographic reconstructions of 5 areas overlaid on the X-ray 
mosaic; D: Single slice of the tomographic reconstruction overlaid with a single slice of the cryo-3D-SIM. 
See S5 for the correlation accuracy map. Scale bar: A B C & D 10 μm. Bottom row: Single slice from a single 
tomographic reconstruction showing the reconstructed absorbance from SXT overlaid with the cryo-SIM 
signal from TPR-Hsp90-AuNC (green) coming from MVBs and from the mitochondria (red) in NIH-3T3 (left) 
and cardiac primary mice fibroblasts (PFib, right). Scale bar 2 μm; Inset 1 μm. N = Nucleus, M = 
Mitochondria, MVB = Multivesicular Bodies, ER = endoplasmic reticulum 
149x193mm (300 x 300 DPI) 
























































































































TPR-Hsp90-AuNC co-localization study on NIH-3T3 and primary mice fibroblasts, respectively, of anti-Alix (A 
& B), anti-Flotillin (C & D) and anti-CD9 (E & F) using confocal microscopy. The inset show the merged (‘), 
green only (Alexa488, ’’) and red (from the respective antibody, ’’’) signals. Scale bars: A; B; E; & F 5 μm; C 
& D 3 μm; Insets for A; B; C & D, 1 μm; Insets for E & F 2 μm 
150x178mm (300 x 300 DPI) 
























































































































Snapshot of a representative tomographic reconstruction for each sample showing the reconstructed 
absorbance value to compare the morphology of the cell after treatment. * = MVB; M = Mitochondria; N = 
Nucleus, ER = endoplasmic reticulum, V = Vacuole, LD = Lipid Droplet, arrow = Nuclear double membrane. 
Scale bar 2 μm 
116x233mm (300 x 300 DPI) 
























































































































Comparison of MVB volumes measured after segmentation using AMIRA. 34 Avg # represents the average 
number of segmented MVBs in a tomogram, Avg V stands for average volume and Med V stands for median 
volume (both in µm3). The measured data was tested for variance and the corresponding t-test was used to 
determine statistically relevant differences between groups, the results of which are shown in the table 
below. 
150x152mm (300 x 300 DPI) 
























































































































Comparison of mitochondrial volumes of both NIH-3T3 and primary mouse fibroblast cells, measured after 
segmentation using AMIRA34. Avg # represents the average number of segmented mitochondria in a 
tomogram, Avg V stands for average volume and Med V stands for median volume (both in µm3). The 
measured data was tested for variance and the corresponding t-test was used to determine statistically 
relevant differences, the results of which are shown in the table below. 
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